Ensysce Biosciences Submits Phase 3 Protocol to the FDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. LFTO
2. CMCSA
3. QNT
4. NVDA
5. VRDN
6. INIO
7. HONA
8. ABBV
9. HON
10. SPY

Go back to Ensysce Biosciences Submits Phase 3 Protocol to the FDA
(NASDAQ: ENSC) Delayed: 0.30 --0 (-0%)
Previous Close $0.30    52 Week High $ 
Open $0.30    52 Week Low $ 
Day High $0.31    P/E N/A 
Day Low $0.29    EPS $ 
Volume 604,003